2018 (10th) International Conference on Stem Cells Will Commence in Beijing, China

New York, NY, October 28, 2018 --(PR.com)-- 2018 (10th) international conference on stem cells will be held in Beijing on November 9, 2018 and concluded on November 10, 2018. Based on the experience of the previous nine sessions of stem cell clinic and transformation, this conference will focus on stem cell reprogramming and regenerative medicine, stem cell clinical research and stem cell commercialization with the invitation of global well-known experts and scholars, industry leaders and clinicians to conduct in-depth discussions for further cooperation and exchanges.

Conference Highlights:

1. Selected topics will be discussed, like stem cell reprogramming, stemness maintenance and directional differentiation, roles of stem cells in tissue & organ repair, enzyme application for stem cell.
2. Directions of stem cell therapy, stem cell storage and preparation automation will be pointed out.
3. Clinicians and experts in this field will be invited to give speeches on clinical translation.

“We will talk about how people put some enzymes and stem cell into effect, such as Stem Cell Activating Enzymes and PTP1B. The research in this field will facilitate a deeper development for properties of stem cell,” said one expert that will attend the discussion during the conference.

About Stem Cell Activating Enzymes and PTP1B:
Stem Cell Activating Enzymes (SCAEs)
SCAEs can inhibit apoptosis and promote proliferation of stem cells, activate dormant stem cells in the body for the growth of stem cells, accelerate metabolism, meanwhile repair and replace damaged cells to fundamentally solve the senescence of dull skin and wrinkles, insomnia, sub-health obesity and hypofunction.

PTP1B belongs to the protein-tyrosine-phosphatase family, and the similar enzymes are Phosphodiesterase 4D (https://www.creative-enzymes.com/similar/PDE4D_527.html) and Phosphodiesterase 5A (https://www.creative-enzymes.com/similar/Phosphodiesterase-5A_556.html). TP1B plays a crucial role in the early development of human embryonic stem cells, it decides whether they will develop into the nervous system or internal organs.

“This conference will give us a further understanding of the stem cell field, including the active effect of enzymes that we are studying (e.g Phosphodiesterase I) (https://www.creative-enzymes.com/similar/PDE-I_522.html) on stem cells, and will open up new ideas for the treatment of multiple diseases,” commented a representative researcher in Creative Enzymes.

About Creative Enzymes
Creative Enzymes, a cutting-edge enzyme products and service provider based in NY, USA, provides enzyme engineering and modification service to help clients with increasing needs in improving enzyme activity and properties and creating perfect biocatalyst for a new reaction. As one of the few companies that provide solutions to those challenges, Creative Enzymes has accumulated high reliability with years of experience in serving companies and research institutes.
Creative Enzymes
Victoria Goshal